Actively Recruiting
Comparing Weekly Subcutaneous and Intravenous Alpha1-Proteinase Inhibitor Doses for Adults with Alpha1-Antitrypsin Deficiency
Led by Grifols Therapeutics LLC · Updated on 2026-10-26
40
Participants Needed
22
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating two different weekly doses of Alpha1-Proteinase Inhibitor Alpha1-PI given by injection under the skin compared with the standard intravenous doses in adults with Alpha-1 Antitrypsin Deficiency. This Phase 3, open-label study aims to understand how the body processes the medicine and to assess the safety and tolerability of the different doses. Participants are randomly assigned to treatment groups in a parallel design, with both doctors and participants aware of the assigned treatment. Participants undergo two treatment periods the first with intravenous IV Liquid Alpha1-PI given weekly at either 60 mgkg or 120 mgkg for 8 weeks, followed by a second period with subcutaneous SC Alpha1-PI 15% injection at corresponding higher doses 90 mgkg or 180 mgkg also given weekly for 8 weeks. Participants receive each dosing schedule sequentially to compare pharmacokinetics and safety between IV and SC administration. During the study, participants have regular visits to monitor steady-state levels of Alpha1-PI in the blood, lung function tests, and safety assessments. Key measurements include the area under the curve AUC of Alpha1-PI over each weekly interval and trough serum levels at specific weeks. The study includes screening, 16 weeks of treatment divided into two 8-week periods, and ongoing safety and tolerability evaluations throughout.
CONDITIONS
Brief Title
A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
Research Team
B
Beatriz Garcia Castro
L
Lydia Martinez Garrido
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here